Current Developments for the Diagnosis and Treatment of Irritable Bowel Syndrome

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|16|33|3638-3645

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.16, Iss.33, 2010-11, pp. : 3638-3645

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rifaximin for the treatment of irritable bowel syndrome

By Cremonini Filippo   Lembo Anthony  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 3, 2012-02 ,pp. : 433-440

Informa Healthcare

Access to resources Recommend Favorite

Asimadoline in the treatment of irritable bowel syndrome

By Mangel Allen W   Williams Valerie SL  

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 10, 2010-10 ,pp. : 1257-1264

Informa Healthcare

Access to resources Recommend Favorite

Recent developments in the therapy of irritable bowel syndrome

By Saad Richard J   Chey William D  

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 2, 2008-02 ,pp. : 117-130

Informa Healthcare

Access to resources Recommend Favorite

Treatment Options for Irritable Bowel Syndrome Set to Increase

By  

Pharmaceutical & Diagnostic Innovation, Vol. 2, Iss. 1, 2004-05 ,pp. : 12-17

Adis International

Access to resources Recommend Favorite

Review of tegaserod in the treatment of irritable bowel syndrome

By Patel Sonal   Berrada Driss   Lembo Anthony  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 11, 2004-11 ,pp. : 2369-2379

Informa Healthcare

Access to resources Recommend Favorite